Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nuclear Export of mRNA02:31

Nuclear Export of mRNA

7.9K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.9K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

10.8K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.8K
mRNA Stability and Gene Expression02:51

mRNA Stability and Gene Expression

5.7K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
5.7K
RNA Stability01:53

RNA Stability

33.9K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.9K
Translation01:31

Translation

15.5K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
15.5K
Types of RNA01:20

Types of RNA

6.3K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering Immunity: Current Progress and Future Directions of CAR-T Cell Therapy.

International journal of molecular sciences·2026
Same author

RNA Therapeutics: Bridging Discovery and Clinical Implementation.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Molecular Mechanisms of Innate Immune Sensing of Exogenous RNAs.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Assessing the Immunogenicity of Synthetic RNA Using Blood Cells.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Large-Scale Production of Unmodified mRNA for Reprogramming Human Dendritic Cells and T Cells.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Production of mRNA-Loaded Dendritic Cell Cancer Vaccines.

Methods in molecular biology (Clifton, N.J.)·2025

Related Experiment Video

Updated: Sep 9, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.3K

Effects of Nucleoside Modifications on mRNA Translation: Choosing the Right Modifications.

Mouldy Sioud1

  • 1Division of Cancer Medicine, Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. mosioud@medisin.uio.no.

Methods in Molecular Biology (Clifton, N.J.)
|August 28, 2025
PubMed
Summary

Advancements in messenger RNA (mRNA) therapeutics leverage modified nucleosides to enhance stability and reduce immune responses. Optimizing modification types and positions is crucial for effective mRNA translation and therapeutic development.

Keywords:
Chemical modificationsIn vitro transcriptionModified nucleosidesN1 methylpseudouridinePseudouridineTranslation

More Related Videos

In Vitro Transcribed RNA-based Luciferase Reporter Assay to Study Translation Regulation in Poxvirus-infected Cells
08:58

In Vitro Transcribed RNA-based Luciferase Reporter Assay to Study Translation Regulation in Poxvirus-infected Cells

Published on: May 1, 2019

15.1K
Highly Efficient Transfection of Primary Macrophages with In Vitro Transcribed mRNA
06:46

Highly Efficient Transfection of Primary Macrophages with In Vitro Transcribed mRNA

Published on: November 9, 2019

22.9K

Related Experiment Videos

Last Updated: Sep 9, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.3K
In Vitro Transcribed RNA-based Luciferase Reporter Assay to Study Translation Regulation in Poxvirus-infected Cells
08:58

In Vitro Transcribed RNA-based Luciferase Reporter Assay to Study Translation Regulation in Poxvirus-infected Cells

Published on: May 1, 2019

15.1K
Highly Efficient Transfection of Primary Macrophages with In Vitro Transcribed mRNA
06:46

Highly Efficient Transfection of Primary Macrophages with In Vitro Transcribed mRNA

Published on: November 9, 2019

22.9K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Vaccinology

Background:

  • The success of messenger RNA (mRNA) vaccines against SARS-CoV-2 has accelerated research into mRNA-based therapeutics.
  • Key innovations involve modified nucleosides and lipid nanoparticle delivery systems.

Purpose of the Study:

  • To detail the production, purification, and translation evaluation of modified mRNA in human cells.
  • To investigate the impact of various 5-position pyrimidine modifications on mRNA therapeutics.

Main Methods:

  • In vitro transcription using phage T7 RNA polymerase with modified ribonucleoside triphosphates.
  • Production and purification of modified mRNA constructs.
  • Assessment of mRNA translation efficiency in human cells.

Main Results:

  • Modified nucleosides are generally tolerated by T7 RNA polymerase.
  • Specific modifications can reduce innate immune activation but have variable effects on translation.
  • The choice of modification and its position significantly influence mRNA translation.

Conclusions:

  • Careful consideration of nucleoside modification type, position, and mRNA sequence is essential for designing effective mRNA therapeutics.
  • Optimized modifications can improve the therapeutic potential of mRNA technology.